<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09580000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P00750</UniProt_ID>
  <Seq_Length>562</Seq_Length>
  <Molecule_Weight>62917</Molecule_Weight>
  <KEGG_ID>hsa:5327</KEGG_ID>
  <Orthology_ID>K01343</Orthology_ID>
  <Function_Summary>Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events. Plays a direct role in facilitating neuronal migration.</Function_Summary>
  <Catalytic_Mechanism>Specific cleavage of Arg-|-Val bond in plasminogen to form plasmin.</Catalytic_Mechanism>
  <Pfam_ID>PF00008:EGF@@PF00039:fn1@@PF00051:Kringle@@PF00089:Trypsin</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Tissue-type plasminogen activator chain A</Alias>
      <Alias>Tissue-type plasminogen activator chain B</Alias>
      <Alias>tPA</Alias>
      <Alias>t-PA</Alias>
      <Alias>t-plasminogen activator</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004252</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).</Detail>
      <Keyword>Serine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008236</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>164</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>34</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications). Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).</Detail>
      <Keyword>Protein modification process</Keyword>
      <Ontology_ID>GO:0006464</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands.</Detail>
      <Keyword>Platelet-derived growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0048008</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.</Detail>
      <Keyword>Response to cAMP</Keyword>
      <Ontology_ID>GO:0051591</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.</Detail>
      <Keyword>Regulation of synaptic plasticity</Keyword>
      <Ontology_ID>GO:0048167</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of ovulation, the release of a mature ovum/oocyte from an ovary.</Detail>
      <Keyword>Positive regulation of ovulation</Keyword>
      <Ontology_ID>GO:0060279</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate.</Detail>
      <Keyword>Synaptic transmission, glutamatergic</Keyword>
      <Ontology_ID>GO:0035249</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>An ongoing process that solubilizes fibrin, chiefly by the proteolytic action of plasmin, resulting in the removal of small blood clots.</Detail>
      <Keyword>Fibrinolysis</Keyword>
      <Ontology_ID>GO:0042730</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.</Detail>
      <Keyword>Response to hypoxia</Keyword>
      <Ontology_ID>GO:0001666</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.</Detail>
      <Keyword>Plasminogen activation</Keyword>
      <Ontology_ID>GO:0031639</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.</Detail>
      <Keyword>Response to glucocorticoid stimulus</Keyword>
      <Ontology_ID>GO:0051384</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.</Detail>
      <Keyword>Negative regulation of proteolysis</Keyword>
      <Ontology_ID>GO:0045861</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The orderly movement of a smooth muscle cell from one site to another, often during the development of a multicellular organism.</Detail>
      <Keyword>Smooth muscle cell migration</Keyword>
      <Ontology_ID>GO:0014909</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.</Detail>
      <Keyword>Response to peptide hormone stimulus</Keyword>
      <Ontology_ID>GO:0043434</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MDAMKRGLCCVLLLCGAVFVSPSQEIHARFRRGARSYQVICRDEKTQMIYQQHQSWLRPVLRSNRVEYCWCNSGRAQCHSVPVKSCSEPRCFNGGTCQQALYFSDFVCQCPEGFAGKCCEIDTRATCYEDQGISYRGTWSTAESGAECTNWNSSALAQKPYSGRRPDAIRLGLGNHNYCRNPDRDSKPWCYVFKAGKYSSEFCSTPACSEGNSDCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDGDAKPWCHVLKNRRLTWEYCDVPSCSTCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMRP</Protein_Seq>
    <DNA_Seq>ATGGCCCTGTCCACTGAGCATCCTCCCGCCACACAGAAACCCGCCCAGCCGGGGCCACCGACCCCACCCCCTGCCTGGAAACTTAAAGGAGGCCGGAGCTGTGGGGAGCTCAGAGCTGAGATCCTACAGGAGTCCAGGGCTGGAGAGAAAACCTCTGCGAGGAAAGGGAAGGAGCAAGCCGTGAATTTAAGGGACGCTGTGAAGCAATCATGGATGCAATGAAGAGAGGGCTCTGCTGTGTGCTGCTGCTGTGTGGAGCAGTCTTCGTTTCGCCCAGCCAGGAAATCCATGCCCGATTCAGAAGAGGAGCCAGATCTTACCAAGTGATCTGCAGAGATGAAAAAACGCAGATGATATACCAGCAACATCAGTCATGGCTGCGCCCTGTGCTCAGAAGCAACCGGGTGGAATATTGCTGGTGCAACAGTGGCAGGGCACAGTGCCACTCAGTGCCTGTCAAAAGTTGCAGCGAGCCAAGGTGTTTCAACGGGGGCACCTGCCAGCAGGCCCTGTACTTCTCAGATTTCGTGTGCCAGTGCCCCGAAGGATTTGCTGGGAAGTGCTGTGAAATAGATACCAGGGCCACGTGCTACGAGGACCAGGGCATCAGCTACAGGGGCACGTGGAGCACAGCGGAGAGTGGCGCCGAGTGCACCAACTGGAACAGCAGCGCGTTGGCCCAGAAGCCCTACAGCGGGCGGAGGCCAGACGCCATCAGGCTGGGCCTGGGGAACCACAACTACTGCAGAAACCCAGATCGAGACTCAAAGCCCTGGTGCTACGTCTTTAAGGCGGGGAAGTACAGCTCAGAGTTCTGCAGCACCCCTGCCTGCTCTGAGGGAAACAGTGACTGCTACTTTGGGAATGGGTCAGCCTACCGTGGCACGCACAGCCTCACCGAGTCGGGTGCCTCCTGCCTCCCGTGGAATTCCATGATCCTGATAGGCAAGGTTTACACAGCACAGAACCCCAGTGCCCAGGCACTGGGCCTGGGCAAACATAATTACTGCCGGAATCCTGATGGGGATGCCAAGCCCTGGTGCCACGTGCTGAAGAACCGCAGGCTGACGTGGGAGTACTGTGATGTGCCCTCCTGCTCCACCTGCGGCCTGAGACAGTACAGCCAGCCTCAGTTTCGCATCAAAGGAGGGCTCTTCGCCGACATCGCCTCCCACCCCTGGCAGGCTGCCATCTTTGCCAAGCACAGGAGGTCGCCCGGAGAGCGGTTCCTGTGCGGGGGCATACTCATCAGCTCCTGCTGGATTCTCTCTGCCGCCCACTGCTTCCAGGAGAGGTTTCCGCCCCACCACCTGACGGTGATCTTGGGCAGAACATACCGGGTGGTCCCTGGCGAGGAGGAGCAGAAATTTGAAGTCGAAAAATACATTGTCCATAAGGAATTCGATGATGACACTTACGACAATGACATTGCGCTGCTGCAGCTGAAATCGGATTCGTCCCGCTGTGCCCAGGAGAGCAGCGTGGTCCGCACTGTGTGCCTTCCCCCGGCGGACCTGCAGCTGCCGGACTGGACGGAGTGTGAGCTCTCCGGCTACGGCAAGCATGAGGCCTTGTCTCCTTTCTATTCGGAGCGGCTGAAGGAGGCTCATGTCAGACTGTACCCATCCAGCCGCTGCACATCACAACATTTACTTAACAGAACAGTCACCGACAACATGCTGTGTGCTGGAGACACTCGGAGCGGCGGGCCCCAGGCAAACTTGCACGACGCCTGCCAGGGCGATTCGGGAGGCCCCCTGGTGTGTCTGAACGATGGCCGCATGACTTTGGTGGGCATCATCAGCTGGGGCCTGGGCTGTGGACAGAAGGATGTCCCGGGTGTGTACACCAAGGTTACCAACTACCTAGACTGGATTCGTGACAACATGCGACCGTGACCAGGAACACCCGACTCCTCAAAAGCAAATGAGATCCCGCCTCTTCTTCTTCAGAAGACACTGCAAAGGCGCAGTGCTTCTCTACAGACTTCTCCAGACCCACCACACCGCAGAAGCGGGACGAGACCCTACAGGAGAGGGAAGAGTGCATTTTCCCAGATACTTCCCATTTTGGAAGTTTTCAGGACTTGGTCTGATTTCAGGATACTCTGTCAGATGGGAAGACATGAATGCACACTAGCCTCTCCAGGAATGCCTCCTCCCTGGGCAGAAAGTGGCCATGCCACCCTGTTTTCAGCTAAAGCCCAACCTCCTGACCTGTCACCGTGAGCAGCTTTGGAAACAGGACCACAAAAATGAAAGCATGTCTCAATAGTAAAAGATAACAAGATCTTTCAGGAAAGACGGATTGCATTAGAAATAGACAGTATATTTATAGTCACAAGAGCCCAGCAGGGCCTCAAAGTTGGGGCAGGCTGGCTGGCCCGTCATGTTCCTCAAAAGCACCCTTGACGTCAAGTCTCCTTCCCCTTTCCCCACTCCCTGGCTCTCAGAAGGTATTCCTTTTGTGTACAGTGTGTAAAGTGTAAATCCTTTTTCTTTATAAACTTTAGAGTAGCATGAGAGAATTGTATCATTTGAACAACTAGGCTTCAGCATATTTATAGCAATCCATGTTAGTTTTTACTTTCTGTTGCCACAACCCTGTTTTATACTGTACTTAATAAATTCAGATATATTTTTCACAGTTTTTCCAAAATCAGAGTGGAATGGTTTTGTTATAGATGCTGTATCCCACTCTTTATTCATGTTCACATTTTAAAATCATTTGGAATTCTGCTTCACTCGCTTAACATATACACAACACCTGTAACATACAAGGCAATGGGCTAGGTGCTCCAGACCGGGAAAAGGAGGGACAGGAATGCTTGGTCTGATGGGCTAATATGGCATTTAGAGAAGTACCAAGGTACAGTGGAGCCGGTCACAAAAGGGCAGACTTGTAGTAGAATTCAGTTGCAAGAGGGATTGGGGAATCTTAAGGAAAAAATAGAATCTTAAGGAAAAAATAACTGGGTGAGACGTGGACTGTGGACAGGTGTGGAAAAGGCACTCTCCATGGAGGTATGAATATGTAGAGGGCCAAGAGAGGGGAGTACAGGGAGAAATGAGTTGAGCTTGTCTGAAGTGAACTTCAGGAAGAGGAACATAGGCTGGAATTTAGATTATGGGGGCTCTGAACACCAAACTGAGTTTGGACTTAATTGACTTCTG</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed </TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell surface</CellLocal>
      <Ontology_ID>GO:0009986</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Stored secretory granule</CellLocal>
      <Ontology_ID>GO:0030141</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Apical part of cell</CellLocal>
      <Ontology_ID>GO:0045177</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Synapse</CellLocal>
      <Ontology_ID>GO:0045202</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PLAT</Gene_Name>
    <Gene_ID>5327</Gene_ID>
    <Genbank_ACCN>NM_000930</Genbank_ACCN>
    <Protein_ACCN>NP_000921</Protein_ACCN>
    <HGNC_ID>9051</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5327</Gene_URL>
    <UCSC_ID>uc003xot.2</UCSC_ID>
    <EMBL_ID>ENSG00000104368</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Carotid Artery Dissection</Disease_Name>
      <Disease_Detail>Carotid Artery Dissection</Disease_Detail>
      <Disease_DB>CRT008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/carotid_artery_dissection?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Artery Disease</Disease_Name>
      <Disease_Detail>Artery Disease</Disease_Detail>
      <Disease_DB>ART111</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/artery_disease?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombophilia, Familial, Due to Decreased Release of Plat</Disease_Name>
      <Disease_Detail>Thrombophilia</Disease_Detail>
      <Disease_DB>THR060</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombophilia_familial_due_to_decreased_release_of_plat?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thromboembolism</Disease_Name>
      <Disease_Detail>Thromboembolism</Disease_Detail>
      <Disease_DB>THR079</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thromboembolism?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Retinal Vein Occlusion</Disease_Name>
      <Disease_Detail>Retinal Vein Occlusion</Disease_Detail>
      <Disease_DB>RTN022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinal_vein_occlusion?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocardial Infarction 2</Disease_Name>
      <Disease_Detail>Myocardial Infarction</Disease_Detail>
      <Disease_DB>MYC058</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_infarction_2?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dysfibrinogenemia</Disease_Name>
      <Disease_Detail>Dysfibrinogenemia</Disease_Detail>
      <Disease_DB>DYS026</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dysfibrinogenemia?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Endophthalmitis</Disease_Name>
      <Disease_Detail>Endophthalmitis</Disease_Detail>
      <Disease_DB>END047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/endophthalmitis?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Plasminogen Activator Inhibitor Type 1 Deficiency</Disease_Name>
      <Disease_Detail>Plasminogen Activator Inhibitor Type 1 Deficiency</Disease_Detail>
      <Disease_DB>PLS018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/plasminogen_activator_inhibitor_type_1_deficiency?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Central Retinal Vein Occlusion</Disease_Name>
      <Disease_Detail>Central Retinal Vein Occlusion</Disease_Detail>
      <Disease_DB>CNT016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/central_retinal_vein_occlusion?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intracranial Embolism</Disease_Name>
      <Disease_Detail>Intracranial Embolism</Disease_Detail>
      <Disease_DB>INT010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intracranial_embolism?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cerebral Hypoxia</Disease_Name>
      <Disease_Detail>Cerebral Hypoxia</Disease_Detail>
      <Disease_DB>CRB090</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cerebral_hypoxia?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Inferior Myocardial Infarction</Disease_Name>
      <Disease_Detail>Inferior Myocardial Infarction</Disease_Detail>
      <Disease_DB>INF013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/inferior_myocardial_infarction?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Retinal Artery Occlusion</Disease_Name>
      <Disease_Detail>Retinal Artery Occlusion</Disease_Detail>
      <Disease_DB>RTN014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinal_artery_occlusion?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Coronary Thrombosis</Disease_Name>
      <Disease_Detail>Coronary Thrombosis</Disease_Detail>
      <Disease_DB>CRN017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/coronary_thrombosis?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Central Serous Chorioretinopathy</Disease_Name>
      <Disease_Detail>Central Serous Chorioretinopathy</Disease_Detail>
      <Disease_DB>CNT060</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/central_serous_chorioretinopathy?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hyperfibrinolysis, Familial, Due to Increased Release of Plat</Disease_Name>
      <Disease_Detail>Hyperfibrinolysis, Familial, Due to Increased Release of Plat</Disease_Detail>
      <Disease_DB>HYP313</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hyperfibrinolysis_familial_due_to_increased_release_of_plat?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Venous Thoracic Outlet Syndrome</Disease_Name>
      <Disease_Detail>Venous Thoracic Outlet Syndrome</Disease_Detail>
      <Disease_DB>VNS012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/venous_thoracic_outlet_syndrome?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Myocardial Infarction</Disease_Name>
      <Disease_Detail>Acute Myocardial Infarction</Disease_Detail>
      <Disease_DB>ACT075</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_myocardial_infarction?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardiac Rupture</Disease_Name>
      <Disease_Detail>Cardiac Rupture</Disease_Detail>
      <Disease_DB>CRD016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardiac_rupture?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Basilar Artery Occlusion</Disease_Name>
      <Disease_Detail>Basilar Artery Occlusion</Disease_Detail>
      <Disease_DB>BSL004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/basilar_artery_occlusion?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Superior Vena Cava Syndrome</Disease_Name>
      <Disease_Detail>Superior Vena Cava Syndrome</Disease_Detail>
      <Disease_DB>SPR035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/superior_vena_cava_syndrome?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ischemia</Disease_Name>
      <Disease_Detail>Ischemia</Disease_Detail>
      <Disease_DB>ISC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ischemia?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Macular Holes</Disease_Name>
      <Disease_Detail>Macular Holes</Disease_Detail>
      <Disease_DB>MCL003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/macular_holes?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Type 3 Von Willebrand Disease</Disease_Name>
      <Disease_Detail>Von Willebrand Disease</Disease_Detail>
      <Disease_DB>TYP018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/type_3_von_willebrand_disease?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thyroid Hormone Resistance Syndrome</Disease_Name>
      <Disease_Detail>Thyroid Hormone Resistance Syndrome</Disease_Detail>
      <Disease_DB>THY019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_hormone_resistance_syndrome?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dissecting Aortic Aneurysm</Disease_Name>
      <Disease_Detail>Dissecting Aortic Aneurysm</Disease_Detail>
      <Disease_DB>DSS004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dissecting_aortic_aneurysm?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pulmonary Embolism</Disease_Name>
      <Disease_Detail>Pulmonary Embolism</Disease_Detail>
      <Disease_DB>PLM033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pulmonary_embolism?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thromboangiitis Obliterans</Disease_Name>
      <Disease_Detail>Thromboangiitis Obliterans</Disease_Detail>
      <Disease_DB>THR006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thromboangiitis_obliterans?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocardial Infarction</Disease_Name>
      <Disease_Detail>Myocardial Infarction</Disease_Detail>
      <Disease_DB>MYC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_infarction?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Candida Glabrata</Disease_Name>
      <Disease_Detail>Candida Glabrata</Disease_Detail>
      <Disease_DB>CND006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/candida_glabrata?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intermediate Coronary Syndrome</Disease_Name>
      <Disease_Detail>Intermediate Coronary Syndrome</Disease_Detail>
      <Disease_DB>INT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intermediate_coronary_syndrome?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombophlebitis</Disease_Name>
      <Disease_Detail>Thrombophlebitis</Disease_Detail>
      <Disease_DB>THR016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombophlebitis?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Coronary Restenosis</Disease_Name>
      <Disease_Detail>Coronary Restenosis</Disease_Detail>
      <Disease_DB>CRN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/coronary_restenosis?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vitreous Detachment</Disease_Name>
      <Disease_Detail>Vitreous Detachment</Disease_Detail>
      <Disease_DB>VTR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vitreous_detachment?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Idiopathic Avascular Necrosis</Disease_Name>
      <Disease_Detail>Idiopathic Avascular Necrosis</Disease_Detail>
      <Disease_DB>IDP069</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/idiopathic_avascular_necrosis?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thoracic Outlet Syndrome</Disease_Name>
      <Disease_Detail>Thoracic Outlet Syndrome</Disease_Detail>
      <Disease_DB>THR013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thoracic_outlet_syndrome?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Central Retinal Artery Occlusion</Disease_Name>
      <Disease_Detail>Central Retinal Artery Occlusion</Disease_Detail>
      <Disease_DB>CNT028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/central_retinal_artery_occlusion?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dengue Shock Syndrome</Disease_Name>
      <Disease_Detail>Dengue Shock Syndrome</Disease_Detail>
      <Disease_DB>DNG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dengue_shock_syndrome?search=PLAT#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intracranial Thrombosis</Disease_Name>
      <Disease_Detail>Intracranial Thrombosis</Disease_Detail>
      <Disease_DB>INT078</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intracranial_thrombosis?search=PLAT#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES</PDB_Title>
      <PDB_ID>1PML</PDB_ID>
      <Resolution>2.38</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PML</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Kringle-kringle interactions in multimer kringle structures.</PubMed_Title>
      <Author>Padmanabhan, K., et al.</Author>
      <Journal>Protein Sci.(1994)3:898-910</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8069221?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF THE FIBRIN BINDING FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE</PDB_Title>
      <PDB_ID>1TPN</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TPN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance.</PubMed_Title>
      <Author>Downing, A.K., et al.</Author>
      <Journal>J.Mol.Biol.(1992)225:821-833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1602484?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE KRINGLE-2 DOMAIN OF TISSUE PLASMINOGEN ACTIVATOR AT 2.4-ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1TPK</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TPK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution.</PubMed_Title>
      <Author>de Vos, A.M., et al.</Author>
      <Journal>Biochemistry(1992)31:270-279</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1310033?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>COMPLEX OF BENZAMIDINE WITH THE CATALYTIC DOMAIN OF HUMAN TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR [(TC)-T-PA]</PDB_Title>
      <PDB_ID>1RTF</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RTF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator</PubMed_Title>
      <Author>Lamba, D., et al.</Author>
      <Journal>J.Mol.Biol.(1996)258:117-135</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8613982?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF THE TISSUE-TYPE PLASMINOGEN ACTIVATOR KRINGLE 2 DOMAIN COMPLEXED TO 6-AMINOHEXANOIC ACID AN ANTIFIBRINOLYTIC DRUG</PDB_Title>
      <PDB_ID>1PK2</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PK2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug.</PubMed_Title>
      <Author>Byeon, I.J., et al.</Author>
      <Journal>J.Mol.Biol.(1991)222:1035-1051</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1762144?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>F1-G MODULE PAIR RESIDUES 1-91 (C83S) OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE)</PDB_Title>
      <PDB_ID>1TPG</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TPG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The solution structure and backbone dynamics of the fibronectin type I and epidermal growth factor-like pair of modules of tissue-type plasminogen activator.</PubMed_Title>
      <Author>Smith, B.O., et al.</Author>
      <Journal>Structure(1995)3:823-833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7582899?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE)</PDB_Title>
      <PDB_ID>1BDA</PDB_ID>
      <Resolution>3.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BDA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.</PubMed_Title>
      <Author>Renatus, M., et al.</Author>
      <Journal>EMBO J.(1997)16:4797-4805</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9305622?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF THE FIBRIN BINDING FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE</PDB_Title>
      <PDB_ID>1TPM</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TPM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance.</PubMed_Title>
      <Author>Downing, A.K., et al.</Author>
      <Journal>J.Mol.Biol.(1992)225:821-833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1602484?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE</PDB_Title>
      <PDB_ID>1A5H</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A5H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors.</PubMed_Title>
      <Author>Renatus, M., et al.</Author>
      <Journal>J.Biol.Chem.(1997)272:21713-21719</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9268299?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05202</Pathway_ID>
      <Pathway_Title>Transcriptional misregulation in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04610</Pathway_ID>
      <Pathway_Title>Complement and coagulation cascades</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.ia.b.c.eb.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1a5h</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Parcq J, et al. Cell Death Differ. 2012 Jun 29. doi: 10.1038/cdd.2012.86.</Site_Reference>
      <Site_Type>Protein-protein interaction allostery</Site_Type>
      <PubMed_ID>22743997</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.21.68</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/21/68.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>